...
首页> 外文期刊>Medicinal chemistry >Synthesis and anti-cancer activities of apigenin derivatives.
【24h】

Synthesis and anti-cancer activities of apigenin derivatives.

机译:芹菜素衍生物的合成及其抗癌活性。

获取原文
获取原文并翻译 | 示例

摘要

A novel series of apigenin derivatives with phloroglucinol or resorcinol as raw materials were synthesized according to Baker-Venaktaraman reaction and their in vitro inhibitory activities on colorectal adenocarcinoma (HT-29) and leucocythemia (HL-60) cell lines were evaluated by the standard methyl thiazole tetrazolium (MTT) method. The results of biological test showed that some of apigenin derivatives possessed stronger anti-cancer activities than apigenin. Compound 6 showed the strongest activity against colorectal adenocarcinoma (HT-29) and leucocythemia (HL-60) cell lines with IC50 valure of 2.03±0.22 μM, 2.25±0.42 μM, it was better than 5-FU (12.92±0.61 μM, 9.56±0.16 μM), which shows a potential compound for colorectal adenocarcinoma and leucocythemia.
机译:以Baker-Venaktaraman反应为原料,合成了一系列以间苯三酚或间苯二酚为原料的芹菜素衍生物系列,并用标准甲基苯丙氨酸甲酯(HT-29)评价了它们对大肠腺癌(HT-29)和白细胞增多症(HL-60)细胞的体外抑制活性。噻唑四唑鎓(MTT)方法。生物学测试结果表明,芹菜素的某些衍生物具有比芹菜素更强的抗癌活性。化合物6对大肠腺癌(HT-29)和白细胞增多症(HL-60)细胞系表现出最强的活性,IC50值分别为2.03±0.22μM,2.25±0.42μM,优于5-FU(12.92±0.61μM, (9.56±0.16μM),显示出结直肠腺癌和白细胞增多症的潜在化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号